Atlas Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-97
| Closed | -$7.69K | – | 958 |
|
|
2022
Q3 | $7.69K | Buy |
+97
| New | +$7.69K | ﹤0.01% | 738 |
|
|
2022
Q2 | – | Sell |
-97
| Closed | -$8.72K | – | 1030 |
|
|
2022
Q1 | $8.72K | Sell |
97
-299
| -76% | -$26.9K | ﹤0.01% | 721 |
|
|
2021
Q4 | $44.3K | Buy |
396
+63
| +19% | +$7.05K | 0.01% | 543 |
|
|
2021
Q3 | $41.9K | Buy |
333
+33
| +11% | +$4.15K | 0.01% | 538 |
|
|
2021
Q2 | $40.6K | Buy |
300
+230
| +329% | +$31.1K | 0.01% | 552 |
|
|
2021
Q1 | $9.5K | Sell |
70
-300
| -81% | -$40.7K | ﹤0.01% | 685 |
|
|
2020
Q4 | $52.1K | Buy |
+370
| New | +$52.1K | 0.01% | 463 |
|
|
2020
Q3 | – | Sell |
-500
| Closed | -$56K | – | 601 |
|
|
2020
Q2 | $56K | Buy |
+500
| New | +$56K | 0.01% | 466 |
|
|
2019
Q3 | – | Sell |
-100
| Closed | -$8.77K | – | 699 |
|
|
2019
Q2 | $8.77K | Buy |
+100
| New | +$8.77K | ﹤0.01% | 602 |
|